Camtek Ltd.
Shortcut
1.01Normalized diluted EPS
+1.9% vs Street
Street
0.99Normalized diluted EPS
November 1 consensus snapshot
Real
0.99Reported normalized EPS
Model download
Explore the assumptions and calculations behind the forecast. This is the agent’s original workbook. Its review didn’t finish, so it hasn’t been checked or repaired.
Shortcut’s reasoning.
Revenue is effectively known: Camtek pre-announced Q3 revenue of $160-161m on 14-Oct-2026 after quarter end; model uses $160.6m (revenue landed above the guidance midpoint in 5 of the last 6 quarters).
Non-GAAP gross margin 52.2% (2Q26 51.4%; CFO targets 53-55% exiting 2026 on volume leverage and Eagle G5/Hawk mix); non-GAAP opex $35.0m (+$2.5m Q/Q, R&D-led) gives non-GAAP operating margin 30.4%.
Financial income $7.6m on ~$816m cash and investments; non-GAAP tax rate 9.0% (last four quarters 7.3-10.0%) gives non-GAAP net income $51.35m.
Diluted EPS adds the if-converted add-back of 2030-note issuance-cost amortisation (~$0.69m; reported EPS has exceeded NI/shares by $0.6-0.9m every quarter since issuance) over 51.6m diluted shares: $1.009 vs $0.99 consensus.
P(beat) 68%: mid-cap cohort prior 0.70 with 4 strict beats in 6 pairs gives 0.686; small net downside adjustment. Historical surprises are $0.00-0.02, so the beat margin is thin.
On the record.
- Reporting period
- FQ3 2026 (quarter ended 2026-09-30)
- Reporting basis
- non-GAAP (normalized EPS) diluted per ordinary share, USD
- Consensus snapshot
- November 1, 2026
- Model / effort
- Opus 5.5 · High effort
- Workbook
- Original workbook · review incomplete
Record history
- Forecast generated
- Nov 1, 2026 at 10:12 PM PST
- First posted
- Nov 2, 2026 at 4:10 PM PST
- Result checked
- Nov 4, 2026 at 12:33 PM PST
Result basis
Previous reports lists Q3 2026 normalized EPS 0.99 USD, matching issuer non-GAAP diluted ordinary-share EPS 0.99, distinct from GAAP diluted EPS 0.84 and basic EPS 0.92. The current normalized EPS panel is absent and provider report dates are dashes. All six frozen normalized histories match by explicit fiscal period, with missing-date diagnostics retained. Item-by-item vendor adjustment identity and financial model acceptance are not established.